Counterweight Ventures’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Hold
1,646
0.21% 66
2026
Q1
$402K Hold
1,646
0.23% 67
2025
Q4
$341K Hold
1,646
0.19% 64
2025
Q3
$305K Hold
1,646
0.18% 66
2025
Q2
$251K Hold
1,646
0.16% 65
2025
Q1
$273K Buy
1,646
+43
+3% +$6.73K 0.2% 64
2024
Q4
$232K Hold
1,603
0.16% 67
2024
Q3
$260K Buy
1,603
+225
+16% +$35.8K 0.18% 65
2024
Q2
$201K Hold
1,378
0.15% 62
2024
Q1
$218K Hold
1,378
0.18% 62
2023
Q4
$216K Buy
+1,378
New +$211K 0.2% 58

Other funds holding JNJ

Counterweight Ventures's JNJ Position: Q2 2026 in Review

Counterweight Ventures held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,646 shares worth $418K. The position accounts for 0.21% of the portfolio, ranked #66.

Counterweight Ventures first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Counterweight Ventures held 1,646 shares of Johnson & Johnson worth $418K as of Q2 2026.
  • Counterweight Ventures left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.21% of Counterweight Ventures's portfolio in Q2 2026, its #66 holding.
  • Counterweight Ventures first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.